FASD - The Course

< Previous      Next >

Page 17 of 17

Module 5: FASD Prevention

    References

1. Stratton, K.; Howe, C.; and Battaglia, F., eds. 1996. Fetal Alcohol Syndrome: Diagnosis, Epidemiology, Prevention, and Treatment. Washington, DC: National Academy Press.



2. Handmaker, N.S., and Wilbourne, P. 2001. Motivational interventions in prenatal clinics. Alcohol Research & Health 25(3):219-229.



3. Chang, G.; Wilkins-Haug, L.; Berman, S.; et al. 1998. Alcohol use and pregnancy: Improving identification. Obstetrics & Gynecology 91:892-898.



4. Sokol, R.J.; Martier, S.S.; Ager, J.W. 1989. The T-ACE questions: Practical prenatal detection of risk-drinking. American Journal of Obstetrics and Gynecology 160 (4):863:870.



5. Prochaska, J., and DiClemente, C. 1986. Toward a comprehensive model of change. In Miller, W.R., and Heather, N., eds. Treating Addictive Behaviors: Processes of Change. New York: Plenum Press, pp. 3-27.



6. Miller, W.R., and Rollnick, S. 1991. Motivational Interviewing: Preparing People to Change Addictive Behavior. New York, NY: Guilford Press.



7. Klein, D., and Zahnd, E. 1997. Perspectives of pregnant substance-abusing women: Findings from the California Perinatal Needs Assessment. Journal of Psychoactive Drugs 29(1):55-66.



8. Kaskutas, L.A. 1996. Pathways to self-help among women for sobriety. American Journal of Drug and Alcohol Abuse 22(2):259-280.



9. Finkelstein, N. 1993. Treatment programming for alcohol and drug-dependent pregnant women. International Journal of Addiction 28(13):1275-1309.



10. Grant, T.M.; Ernst, C.C.; and Streissguth, A.P. 1999. Intervention with high-risk alcohol and drug-abusing mothers: I. Administrative strategies of the Seattle model of paraprofessional advocacy. Journal of Community Psychology 27(1):1-18.



11. Ernst, C.C.; Grant, T.M.; Streissguth, A.P.; et al. 1999. Intervention with high-risk alcohol and drug-abusing mothers: II. Three-year finds from the Seattle model of paraprofessional advocacy. Journal of Community Psychology 27(1):19-38.



12. Chavkin, W., and Breitbart, V. 1997. Substance abuse and maternity: The United States as a case study. Addiction 92(9):1201-1205.



13. May, P.A. 1995. A multiple-level comprehensive approach to the prevention of fetal alcohol syndrome (FAS) and other alcohol-related birth defects (ARBD). International Journal of Addiction 30:1549-1602.



14. Berkowitz, G.; Brindis, C.; Clayson, Z.; et al. 1996. Options for recovery: Promoting success among women mandated to treatment. Journal of Psychoactive Drugs 28(1):31-38.



15. Loneck, B.; Garrett, J.; and Banks, S.M. 1997. Engaging and retaining women in outpatient alcohol and other drug treatment: The effect of referral intensity. Health and Social Work 22(1):38-46.



16. Streissguth, A.P.; Barr, H.M.; Kogan, J.; et al. 1996. Final Report: Understanding the Occurrence of Secondary Disabilities in Clients with Fetal Alcohol Syndrome (FAS) and Fetal Alcohol Effects (FAE). Seattle: University of Washington Publication Services.



17. Streissguth, A. 1997. Fetal Alcohol Syndrome. A Guide for Families and Communities. Baltimore: Paul H. Brookes Publishing Co. 1996.



18. May, P.A. Research issues in the prevention of FAS and ARBD. In Howard, J.M.; Martin, S.E.; Mail, P.D.; et al., eds. Women and Alcohol: Issues for Prevention Research. NIAAA Research Monograph 32. NIH Pub. No. 96-3817. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism, pp. 93-131.



19. Ihlen, B.M.; Amundsen, A.; Sande, H.A.; et al. 1990. Changes in the use of intoxicants after onset of pregnancy. British Journal of Addiction 85:1627-1631.



20. Rubin, D.H.; Krasilnikoff, P.A.; Leventhal, J.M.; et al. 1988. Cigarette smoking and alcohol consumption during pregnancy by Danish women and their spouses—A potential source of fetal morbidity. American Journal of Drug and Alcohol Abuse 14(3):405-417.



21. Zlotnick, C.; Franchino, K.; St. Claire, N.; et al. 1996. The impact of outpatient drug services on abstinence among pregnant and parenting women. Journal of Substance Abuse Treatment 13(3):195-202.

< Previous      Next >

Page 17 of 17